Adoptive immunotherapy by NK and cytotoxic T lymphocytes cells prolongs survival in non-small cell lung cancer | Immunology and Biotherapies | Scoop.it
From www.sciencedirect.com - September 24, 2014 10:04 AM
Highlights

 

•

Ex vivo expansion could derive NKTm cells with high proliferation efficiency.

•

NKTm immunotherapy prolongs OS and increases 2-year survival rate of NSCLC patients.

•

NKTm immunotherapy is an independent risk factor for OS of NSCLC patients.


Via Krishan Maggon